Mylan Draws 483 for Cleaning and Maintenance, Quality Control Issues

Drug Industry Daily
A A
A heavily staffed FDA inspection of pharmaceutical giant Mylan’s manufacturing facility in Morgantown, West Virginia netted the company a lengthy Form 483 listing numerous deficiencies in the firm’s quality control unit.

To View This Article:

Login

Subscribe To Drug Industry Daily